GSE114003
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene
Monitor HBV mRNA reduction in response to Tazarotene and to identify global transcriptome-wide gene expression associated with Tazarotene treatment in HBV infected PHH using RNA-Seq Overall design: HBV infected PHH treated with Tazarotene 1 µM or DMSO, time points 8h, 48h